Fertility Turkey – IVF in Turkey


PGT-M, formerly known as PGD, is preimplantation genetic testing for monogenic/single-gene diseases. If the couple or their relatives have a single gene disease or a disorder caused by a mutation in a single gene, there is a risk that the child will have that genetic defect. Although PGT-M is not necessary for all patients, it is extremely important for those who may be carriers of a genetic disease. The benefit of PGT-M is that it prevents the risk of passing the single gene disease in the family to the child by choosing healthy embryos. It also significantly reduces miscarriages and IVF failures.

PGT-M can identify many genetic disorders, including:

  • Cystic Fibrosis
  • Fragile-X syndrome
  • Spinal Muscular Atrophy
  • Huntington’s disease
  • Becker’s muscular dystrophy
  • Beta thalassemia
  • Charcot-Marie-Tooth disease 1A
  • Muscular dystrophy
  • Familiar amyloid polyneuropathy
  • Hemophilia A (F8)
  • Hemophilia B (F9)
  • Multiple endocrine neoplasia, type 2A
  • Myotonic dystrophy (Steinert’s disease)
  • RhD incompatibility
  • Spinal muscular atrophy

PGT-M is performed with a biopsy sample taken from the embryo on the 3rd or 5th day of embryo development. The test results in a couple of weeks. During this time, the embryos are frozen and stored in the laboratory. According to the test result, the healthy embryo is transferred to the uterus.

Ask the Doctor

Enter your details in the form and we will call you back.